Omnicell, Inc. (NASDAQ:OMCL) Shares Purchased by Prudential Financial Inc.

Prudential Financial Inc. boosted its stake in Omnicell, Inc. (NASDAQ:OMCL) by 26.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 231,053 shares of the company’s stock after acquiring an additional 48,193 shares during the period. Prudential Financial Inc. owned about 0.50% of Omnicell worth $10,286,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Advantage Alpha Capital Partners LP boosted its position in shares of Omnicell by 14.9% in the 4th quarter. Advantage Alpha Capital Partners LP now owns 52,041 shares of the company’s stock valued at $2,317,000 after purchasing an additional 6,753 shares during the period. Vanguard Group Inc. lifted its stake in Omnicell by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 5,562,165 shares of the company’s stock valued at $247,628,000 after buying an additional 28,573 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of Omnicell in the fourth quarter valued at approximately $436,000. Hillsdale Investment Management Inc. grew its position in shares of Omnicell by 0.5% during the fourth quarter. Hillsdale Investment Management Inc. now owns 92,897 shares of the company’s stock worth $4,136,000 after acquiring an additional 420 shares during the last quarter. Finally, Sei Investments Co. acquired a new position in shares of Omnicell in the 4th quarter valued at $313,000. Institutional investors and hedge funds own 97.70% of the company’s stock.

Omnicell Stock Performance

Shares of OMCL stock opened at $35.01 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.22 and a debt-to-equity ratio of 0.13. Omnicell, Inc. has a 12-month low of $25.12 and a 12-month high of $55.75. The company has a market cap of $1.64 billion, a price-to-earnings ratio of 129.67, a price-to-earnings-growth ratio of 7.53 and a beta of 0.85. The stock has a 50 day simple moving average of $39.01 and a 200-day simple moving average of $42.58.

Omnicell (NASDAQ:OMCL) last released its earnings results on Thursday, February 6th. The company reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.12). Omnicell had a net margin of 1.13% and a return on equity of 3.82%. On average, equities analysts forecast that Omnicell, Inc. will post 1.09 EPS for the current year.

Analyst Ratings Changes

Several research analysts have issued reports on OMCL shares. Benchmark reissued a “buy” rating and set a $62.00 price objective on shares of Omnicell in a research report on Tuesday, February 4th. StockNews.com lowered Omnicell from a “buy” rating to a “hold” rating in a report on Monday, March 24th. Bank of America reduced their price objective on Omnicell from $54.00 to $46.00 and set a “neutral” rating for the company in a research note on Monday, January 6th. Wells Fargo & Company lowered their target price on Omnicell from $49.00 to $40.00 and set an “equal weight” rating on the stock in a research note on Monday, January 13th. Finally, JPMorgan Chase & Co. dropped their target price on Omnicell from $44.00 to $36.00 and set a “neutral” rating on the stock in a report on Thursday, March 20th. Five analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $51.00.

Omnicell Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.